Biodefense & chemical defense: open SBIR/STTR topics
3 open or upcoming topics mention biodefense & chemical defense, across 2 agencies. Matched by keywords in the topic title and description.
DIRECT TO PHASE II: Minimally Invasive Remote Blood Collection Device for Free-Ranging Cetaceans
Navy bottlenose dolphins are valuable Fleet assets whose health and well-being are essential to sustaining mine countermeasures, port security, and object recovery missions.
TRIAGE-X: Autonomous Casualty Triage and Treatment in Chemically Contaminated Mass Casualty Events
DARPA seeks innovative approaches to autonomous chemical, biological, radioactive, and nuclear (CBRN) triage that measurably improve casualty survival and increase the effective capacity of a medical response during CBRN disasters.
Universal Platform for Living Adaptive Toxin-removal (UNI-PLAT)
The purpose of this topic area is to catalyze the development of a universal, “plug-and-play” synthetic biology platform that enables next-generation microbial chassis capable of performing a broad array of programmable functions.
Past SBIR/STTR awards in biodefense & chemical defense
Since 2021, SBIR.gov records 177 SBIR/STTR awards worth $96.9M here. Top agencies: Defense (61), Health and Human Services (57), National Science Foundation (21), Agriculture (17), Homeland Security (12), Commerce (5). Most frequent awardees: LYNNTECH INC. (9), NANOHMICS INC (5), NANOSONIC INC. (3), CFD RESEARCH CORPORATION (3), PHYSICAL SCIENCES INC. (3), XCMR INC (3).
- A biosecurity platform for the identification of natural and engineered biological threats by ACLID, INC. (Phase I, Defense, 2023, $74,933)
- An Artificial Intelligence (AI) – Based 3 Dimension (3D) Building Model Generation Capability for Chemical Biological Radiological and Nuclear (CBRN) Situational Awareness (SA) and Hazard Modeling by AERIS LLC (Phase I, Defense, 2023, $182,999)
- Bugs Away by AGARVEY LLC (Phase I, Defense, 2023, $75,000)
- Development of a Novel Injectable Antibiotic to Treat Serious Multidrug-resistant Gram-positive Infections by AIMMAX THERAPEUTICS INC (Phase I, Health and Human Services, 2023, $306,954)
- Use of novel fluorescent tracers to develop a comprehensive retinal biomarker database that maps the heterogeneity of Alzheimer's pathogenesis by Amydis Diagnostics Inc. (Phase II, Health and Human Services, 2023, $1,704,372)
- Intelligent Wind Estimation for CBRN Agent Tracking and Localization by BARRON ASSOCIATES, INC. (Phase II, Defense, 2023, $749,995)
- A portable quantitative polymerase chain reaction platform (qPCR) for rapid detection of pathogens impacting model organisms in animal facilities by BAY GENOMICS, LLC (Phase I, Health and Human Services, 2023, $255,006)
- SBIR Phase II:Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections by BIOAMP DIAGNOSTICS INC (Phase II, National Science Foundation, 2023, $1,000,000)
- Robust operations of ultra-high throughput cell lineage tracking for rapid bioengineering and pathogen detection by Bifrost Biosystems, Inc. (Phase II, Defense, 2023, $1,496,610)
- A nanosized magnetic particle system for fast and efficient neuronal extracellular vesicle enrichment from plasma by CAPTIS DIAGNOSTICS (Phase I, Health and Human Services, 2023, $306,509)
Source: SBIR.gov public award dataset, matched by keywords. Not an official classification.
Related areas: Sensors & sensing · Medical devices & diagnostics · Maritime & undersea · Autonomy & robotics · Environment, water & climate
Get new SBIR/STTR topics every week
New topics, plus everything closing in the next 14 days. Free, one email a week.